Reason to trust
How Our News is Made
Strict editorial policy that focuses on accuracy, relevance, and impartiality
Ad discliamer
Morbi pretium leo et nisl aliquam mollis. Quisque arcu lorem, ultricies quis pellentesque nec, ullamcorper eu odio.
Eagle-eyed investors are constantly seeking financial instruments that have the potential to generate high returns. Sometimes their investment hopes go up in smoke, alas.
Experienced traders will have noticed how the medical marijuana market has exploded – in 2017 record growth for the legal cannabis industry saw total economic output reach $16 billion – and could well be tempted to invest.
The upward trend is expected to continue, with significant further growth projected in the coming years, as the legalization of medical marijuana around the world gradually becomes more widespread.
Indeed, the global legal cannabis market, led by growth in North America and Europe in particular, is forecast to hit $57 billion by 2027, according to ArcView Market Research and BDS Analytics.
Public opinion on medical marijuana is changing, and more people are convinced it should be considered as a viable option for safe and effective pain management. This is partly thanks to a vast amount of detailed and extensive research in this area that has reassured citizens and politicians alike.
The recent breakthrough legislation reflects this greater acceptance. The indications are that the favourable stances on marijuana production and sales taken in Canada and America mean it is likely other countries – including the UK, Germany, Italy, and France – could follow their lead. Legal cannabis sales in North America grew by an unprecedented 30 per cent in 2016, and then 33 per cent last year, leading analytical research reveals.
A cluster of licensed North American organizations have already been able to expand globally in a short timescale. They have started to export cannabis products worldwide as well as begun to establish production contracts in Europe, South America, Asia, Africa, and Australasia. In addition, the cannabis industry has proven itself to be a financial boon for governments, by generating both new jobs and tax revenue.
Further expansion in the industry appears imminent, meaning that now could be the perfect time to open a buy position and invest in medical marijuana, well before it reaches its sizeable potential, as predicted by various analysts.
But how to gain exposure to one of the most intriguing fields in modern biotechnology? From September 17 you can invest using a unique investment strategy, which groups together many leading organizations in the cannabis industry. The CannabisCare CopyPortfolio groups together stocks from many of the leading North American companies in this space.
Earlier this year eToro chief executive Yoni Assia said: “We are looking at an interesting industry emerging in the public sector: cannabis.” Now it has happened. His organization has a reputation for being pioneering, and once again eToro is attempting to make trading as straightforward as possible and offering attractive financial instruments.
The first CopyPortfolio, eToro’s latest tech-power innovation, was launched in the February 2016. Now eToro users and eagle-eyed traders alike can invest using eToro’s latest CopyPortfolio, CannabisCare. The team behind the award-winning platform has helpfully created this explainer video to coincide with the launch.
Note that once the CannabisCare CopyPortfolio has reached 1,000 investors on any day, eToro will close the portfolio for new investments at 23:59 GMT on that day. And with luck, those who back medical marijuana will enjoy success.
To discover more about eToro’s latest CopyPortfolio, CannabisCare, please visit https://www.etoro.com/funds/cannabiscare now.
This is not investment advice. Past performance is not an indication of future results. Your capital is at risk.
Disclaimer: The opinions expressed in this article do not represent the views of NewsBTC or any of its team members. NewsBTC is neither responsible nor liable for the accuracy of any of the information supplied in Sponsored Stories/Press Releases such as this one.
